IL17A and psoriasis: For psoriasis, it is now well established that interleukin IL-17 is involved in the formation of the skin lesions, a notion recently confirmed in humans by the success of monoclonal antibodies against IL-17A or the receptor IL-17RA in controlling and reversing the skin disease [89].